Home / All Categories / Medical Care / Global Prostate Cancer Treatment Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Global Prostate Cancer Treatment Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Global Prostate Cancer Treatment Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Pages: 121      Published Date: Oct 2018       Category: Medical Care
Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players are investing in research for the development of therapeutic products for the treatment of such tumors. For instance, there is a strong pipeline of products such as Tc-99m (Progenics), radium-223 dichloride (Xofigo, Bayer), ODM-201 (Orion and Bayer), which are in their phase 3 studies and are projected to enter the market in the near future. In addition, many generic products are likely to enter the market owing to the expiry of patents of the major existing products during the forecast period. Thus, these factors are expected to drive growth.

Scope of the Report:
Asia Pacific is anticipated to be the fastest growing market over the forecast period. Rising awareness of such tumors would primarily drive growth. Governments of various countries in this region are playing a vital role in creating awareness through programs and online portals that provide detailed information regarding screening & diagnosis through PSA blood tests and DRE for male patients over 50 years of age.
The global Prostate Cancer Treatment Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Prostate Cancer Treatment Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Prostate Cancer Treatment Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Prostate Cancer Treatment Drugs market by product type and applications/end industries.

Market Segment by Companies, this report covers
    Johnson & Johnson
    Astella
    Sanofi
    Ipsen
    Bayer
    AstraZeneca
    Dendreon

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
    Zytiga
    Gonax
    Lupron
    Zoladex
    Decapeptyl
    Eligard
    Vantas
    Casodex
    Others

Market Segment by Applications, can be divided into
    Hospitals
    Ambulatory Surgical Centers
Table of Contents

1 Prostate Cancer Treatment Drugs Market Overview
    1.1 Product Overview and Scope of Prostate Cancer Treatment Drugs
    1.2 Classification of Prostate Cancer Treatment Drugs by Types
        1.2.1 Global Prostate Cancer Treatment Drugs Revenue Comparison by Types (2017-2023)
        1.2.2 Global Prostate Cancer Treatment Drugs Revenue Market Share by Types in 2017
        1.2.3 Zytiga
        1.2.4 Gonax
        1.2.5 Lupron
        1.2.6 Zoladex
        1.2.7 Decapeptyl
        1.2.8 Eligard
        1.2.9 Vantas
        1.2.10 Casodex
        1.2.11 Others
    1.3 Global Prostate Cancer Treatment Drugs Market by Application
        1.3.1 Global Prostate Cancer Treatment Drugs Market Size and Market Share Comparison by Applications (2013-2023)
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
    1.4 Global Prostate Cancer Treatment Drugs Market by Regions
        1.4.1 Global Prostate Cancer Treatment Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
        1.4.1 North America (USA, Canada and Mexico) Prostate Cancer Treatment Drugs Status and Prospect (2013-2023)
        1.4.2 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Treatment Drugs Status and Prospect (2013-2023)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Treatment Drugs Status and Prospect (2013-2023)
        1.4.4 South America (Brazil, Argentina, Colombia) Prostate Cancer Treatment Drugs Status and Prospect (2013-2023)
        1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Treatment Drugs Status and Prospect (2013-2023)
    1.5 Global Market Size of Prostate Cancer Treatment Drugs (2013-2023)
2 Manufacturers Profiles
    2.1 Johnson & Johnson
        2.1.1 Business Overview
        2.1.2 Prostate Cancer Treatment Drugs Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 Johnson & Johnson Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2016-2017)
    2.2 Astella
        2.2.1 Business Overview
        2.2.2 Prostate Cancer Treatment Drugs Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Astella Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2016-2017)
    2.3 Sanofi
        2.3.1 Business Overview
        2.3.2 Prostate Cancer Treatment Drugs Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 Sanofi Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2016-2017)
    2.4 Ipsen
        2.4.1 Business Overview
        2.4.2 Prostate Cancer Treatment Drugs Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Ipsen Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2016-2017)
    2.5 Bayer
        2.5.1 Business Overview
        2.5.2 Prostate Cancer Treatment Drugs Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 Bayer Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2016-2017)
    2.6 AstraZeneca
        2.6.1 Business Overview
        2.6.2 Prostate Cancer Treatment Drugs Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 AstraZeneca Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2016-2017)
    2.7 Dendreon
        2.7.1 Business Overview
        2.7.2 Prostate Cancer Treatment Drugs Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Dendreon Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2016-2017)
3 Global Prostate Cancer Treatment Drugs Market Competition, by Players
    3.1 Global Prostate Cancer Treatment Drugs Revenue and Share by Players (2013-2018)
    3.2 Market Concentration Rate
        3.2.1 Top 5 Prostate Cancer Treatment Drugs Players Market Share
        3.2.2 Top 10 Prostate Cancer Treatment Drugs Players Market Share
    3.3 Market Competition Trend
4 Global Prostate Cancer Treatment Drugs Market Size by Regions
    4.1 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Regions
    4.2 North America Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    4.3 Europe Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    4.4 Asia-Pacific Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    4.5 South America Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    4.6 Middle East and Africa Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
5 North America Prostate Cancer Treatment Drugs Revenue by Countries
    5.1 North America Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
    5.2 USA Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    5.3 Canada Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    5.4 Mexico Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
6 Europe Prostate Cancer Treatment Drugs Revenue by Countries
    6.1 Europe Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
    6.2 Germany Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    6.3 UK Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    6.4 France Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    6.5 Russia Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    6.6 Italy Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Prostate Cancer Treatment Drugs Revenue by Countries
    7.1 Asia-Pacific Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
    7.2 China Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    7.3 Japan Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    7.4 Korea Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    7.5 India Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    7.6 Southeast Asia Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
8 South America Prostate Cancer Treatment Drugs Revenue by Countries
    8.1 South America Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
    8.2 Brazil Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    8.3 Argentina Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    8.4 Colombia Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Prostate Cancer Treatment Drugs by Countries
    9.1 Middle East and Africa Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
    9.2 Saudi Arabia Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    9.3 UAE Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    9.4 Egypt Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    9.5 Nigeria Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
    9.6 South Africa Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
10 Global Prostate Cancer Treatment Drugs Market Segment by Type
    10.1 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Type (2013-2018)
    10.2 Global Prostate Cancer Treatment Drugs Market Forecast by Type (2018-2023)
    10.3 Zytiga Revenue Growth Rate (2013-2023)
    10.4 Gonax Revenue Growth Rate (2013-2023)
    10.5 Lupron Revenue Growth Rate (2013-2023)
    10.6 Zoladex Revenue Growth Rate (2013-2023)
    10.7 Decapeptyl Revenue Growth Rate (2013-2023)
    10.8 Eligard Revenue Growth Rate (2013-2023)
    10.9 Vantas Revenue Growth Rate (2013-2023)
    10.10 Casodex Revenue Growth Rate (2013-2023)
    10.11 Others Revenue Growth Rate (2013-2023)
11 Global Prostate Cancer Treatment Drugs Market Segment by Application
    11.1 Global Prostate Cancer Treatment Drugs Revenue Market Share by Application (2013-2018)
    11.2 Prostate Cancer Treatment Drugs Market Forecast by Application (2018-2023)
    11.3 Hospitals Revenue Growth (2013-2018)
    11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
12 Global Prostate Cancer Treatment Drugs Market Size Forecast (2018-2023)
    12.1 Global Prostate Cancer Treatment Drugs Market Size Forecast (2018-2023)
    12.2 Global Prostate Cancer Treatment Drugs Market Forecast by Regions (2018-2023)
    12.3 North America Prostate Cancer Treatment Drugs Revenue Market Forecast (2018-2023)
    12.4 Europe Prostate Cancer Treatment Drugs Revenue Market Forecast (2018-2023)
    12.5 Asia-Pacific Prostate Cancer Treatment Drugs Revenue Market Forecast (2018-2023)
    12.6 South America Prostate Cancer Treatment Drugs Revenue Market Forecast (2018-2023)
    12.7 Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Data Source
List of Tables and Figures

Figure Prostate Cancer Treatment Drugs Picture
Table Product Specifications of Prostate Cancer Treatment Drugs
Table Global Prostate Cancer Treatment Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Types in 2017
Figure Zytiga Picture
Figure Gonax Picture
Figure Lupron Picture
Figure Zoladex Picture
Figure Decapeptyl Picture
Figure Eligard Picture
Figure Vantas Picture
Figure Casodex Picture
Figure Others Picture
Table Global Prostate Cancer Treatment Drugs Revenue (Million USD) by Application (2013-2023)
Figure Prostate Cancer Treatment Drugs Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Ambulatory Surgical Centers Picture
Table Global Market Prostate Cancer Treatment Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Prostate Cancer Treatment Drugs Type and Applications
Table Johnson & Johnson Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Astella Basic Information, Manufacturing Base and Competitors
Table Astella Prostate Cancer Treatment Drugs Type and Applications
Table Astella Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Prostate Cancer Treatment Drugs Type and Applications
Table Sanofi Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen Basic Information, Manufacturing Base and Competitors
Table Ipsen Prostate Cancer Treatment Drugs Type and Applications
Table Ipsen Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Prostate Cancer Treatment Drugs Type and Applications
Table Bayer Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Prostate Cancer Treatment Drugs Type and Applications
Table AstraZeneca Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Dendreon Basic Information, Manufacturing Base and Competitors
Table Dendreon Prostate Cancer Treatment Drugs Type and Applications
Table Dendreon Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global Prostate Cancer Treatment Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Prostate Cancer Treatment Drugs Revenue Share by Players (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Revenue Share by Players in 2016
Figure Global Prostate Cancer Treatment Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players Prostate Cancer Treatment Drugs Revenue Market Share in 2017
Figure Global Top 10 Players Prostate Cancer Treatment Drugs Revenue Market Share in 2017
Figure Global Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Prostate Cancer Treatment Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Prostate Cancer Treatment Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Regions in 2017
Figure North America Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure South America Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table North America Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
Table North America Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure USA Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure Canada Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Europe Prostate Cancer Treatment Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Germany Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure UK Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure France Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Prostate Cancer Treatment Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure China Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure Japan Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure Korea Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure India Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table South America Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
Table South America Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Brazil Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Prostate Cancer Treatment Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure UAE Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Global Prostate Cancer Treatment Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Prostate Cancer Treatment Drugs Revenue Share by Type (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Revenue Share by Type (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Revenue Share by Type in 2017
Table Global Prostate Cancer Treatment Drugs Revenue Forecast by Type (2018-2023)
Figure Global Prostate Cancer Treatment Drugs Market Share Forecast by Type (2018-2023)
Figure Global Zytiga Revenue Growth Rate (2013-2018)
Figure Global Gonax Revenue Growth Rate (2013-2018)
Figure Global Lupron Revenue Growth Rate (2013-2018)
Figure Global Zoladex Revenue Growth Rate (2013-2018)
Figure Global Decapeptyl Revenue Growth Rate (2013-2018)
Figure Global Eligard Revenue Growth Rate (2013-2018)
Figure Global Vantas Revenue Growth Rate (2013-2018)
Figure Global Casodex Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Prostate Cancer Treatment Drugs Revenue by Application (2013-2018)
Table Global Prostate Cancer Treatment Drugs Revenue Share by Application (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Revenue Share by Application (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Revenue Share by Application in 2017
Table Global Prostate Cancer Treatment Drugs Revenue Forecast by Application (2018-2023)
Figure Global Prostate Cancer Treatment Drugs Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Prostate Cancer Treatment Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Prostate Cancer Treatment Drugs Revenue Market Forecast (2018-2023)
Figure Europe Prostate Cancer Treatment Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Prostate Cancer Treatment Drugs Revenue Market Forecast (2018-2023)
Figure South America Prostate Cancer Treatment Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Forecast (2018-2023)
Johnson & Johnson
Astella
Sanofi
Ipsen
Bayer
AstraZeneca
Dendreon
Request sample
If you need any reports sample, just let us know
Request message: *
Your Name: *
Email Address: *
Country:
Phone Number:
Verification code: *
 
We aim to respond to all request on the same business day.

Purchase this Market Research Report

Single User License $3,480.00
Multi User License $5,220.00
Corporate Users License $6,960.00
Add to Cart Buy Now
goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico